|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
JST136444180 |
003 |
DE-627 |
005 |
20240105092516.0 |
007 |
cr uuu---uuuuu |
008 |
240105s2018 xx |||||o 00| ||eng c |
035 |
|
|
|a (DE-627)JST136444180
|
035 |
|
|
|a (JST)48516894
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Armstead, Theresa L.
|e verfasserin
|4 aut
|
245 |
1 |
4 |
|a The Use of the Data-to-Action Framework in the Evaluation of CDC’s DELTA FOCUS Program
|
264 |
|
1 |
|c 2018
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
520 |
|
|
|a The Centers for Disease Control and Prevention’s (CDC’s) Domestic Violence Prevention Enhancements and Leadership Through Alliances, Focusing on Outcomes for Communities United with States (DELTA FOCUS) program is a 5-year cooperative agreement (2013-2018) funding 10 state domestic violence coalitions and local coordinated community response teams to engage in primary prevention of intimate partner violence. Grantees’ prevention strategies were often developmental and emergent; therefore, CDC’s approach to program oversight, administration, and support to grantees required a flexible approach. CDC staff adopted a Data-to-Action Framework for the DELTA FOCUS program evaluation that supported a culture of learning to meet dynamic and unexpected information needs. Briefly, a Data-to-Action Framework involves the collection and use of information in real time for program improvement. Utilizing this framework, the DELTA FOCUS data-to-action process yielded important insights into CDC’s ongoing technical assistance, improved program accountability by providing useful materials, and information for internal agency leadership, and helped build a learning community among grantees. CDC and other funders, as decision makers, can promote program improvements that are data-informed by incorporating internal processes supportive of ongoing data collection and review.
|
540 |
|
|
|a Copyright © 2018 Wolters Kluwer Health, Inc.
|
655 |
|
4 |
|a research-article
|
700 |
1 |
|
|a Kearns, Megan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rambo, Kirsten
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Estefan, Lianne Fuino
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Dills, Jenny
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rivera, Moira S.
|e verfasserin
|4 aut
|
700 |
1 |
|
|a El-Beshti, Rasha
|e verfasserin
|4 aut
|
773 |
1 |
8 |
|g volume:24
|g year:2018
|g month:02
|g pages:S51-S58
|
856 |
4 |
0 |
|u https://www.jstor.org/stable/48516894
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a GBV_JST
|
951 |
|
|
|a AR
|
952 |
|
|
|d 24
|j 2018
|c 02
|h S51-S58
|